Results 211 to 220 of about 351,102 (361)

Hypoglycemic Encephalopathy. [PDF]

Clin Case Rep
Li DD, Xu BP, Liu BY, Wang HM, Yang H.
europepmc   +1 more source

Abstract No. 156 Comparing MELD, MELD-Na, and MELD 3.0 as Predictors of Survival and Hepatic Encephalopathy After Primary TIPS Placement [PDF]

Arundeep Kaur Lamba, Eman Hasan, Ian Rumball, Ethan Davoudzadeh, Nayan Tiwary, A. Giammarino, Sanjaya K. Satapathy, Craig Greben, J. Weinstein   +8 more
openalex   +1 more source

Lennox–Gastaut syndrome in a patient with biallelic TELO2 variants

Epileptic Disorders, EarlyView.
Melissa Odabassian, Kenneth A. Myers
wiley   +1 more source

Inroads into epilepsy through high‐frequency oscillations: Achievements and benchmark areas for improvement

Epilepsia, EarlyView.
Abstract High‐frequency oscillations (HFOs) were discovered more than 20 years ago, and since then they have been studied intensively in the context of epilepsy. HFOs encompass a broad spectrum of oscillations, typically ranging from 80 Hz to several kHz, that include both normal and pathological oscillations, documented in people with epilepsy and ...
Christos Panagiotis Lisgaras, Birgit Frauscher, Jean Gotman, Julia Jacobs, Philippe Kahane, Richard J. Staba, Maeike Zijlmans   +6 more
wiley   +1 more source

Lingual Asterixis in Hepatic Encephalopathy. [PDF]

ACG Case Rep J
Almazan E, Saju R, Lepe GM, Roberts N, Gardner CA, Carbo A.   +5 more
europepmc   +1 more source

Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota

, 2012
Matteo Garcovich
openalex   +1 more source

Dexamethasone-associated posterior reversible encephalopathy syndrome [PDF]

, 2016
Steven P. Ludlow, Charlene Whittlesey, Megan Bainbridge   +2 more
openalex   +1 more source

Continuous outcome estimation in N‐of‐1 trials for accelerated decision‐making

Epilepsia, EarlyView.
Abstract Objective N‐of‐1 trials aim to determine the therapeutic effect for a single individual. This individualized approach necessitates collecting multiple data points over time through repeated alternating periods of active treatment and a comparator or control condition.
Victoria Defelippe, František Bartoš, Eric‐Jan Wagenmakers, Kees P. J. Braun, Floor E. Jansen, Willem M. Otte   +5 more
wiley   +1 more source

P.016 A novel de novo GABRA1 mutation linked to epileptic encephalopathy: pathophysiology and potential therapeutic options [PDF]

, 2018
Michelle Chiu, Yunfei Bai, Eh Chan, Linda Huh, Ilaria Guella, MJ Farrer, Mary Connolly, L Liu, Michelle Demos, Y Wang   +9 more
openalex   +1 more source

De novo TANC2 stop‐loss variant associated with developmental impairment and drug‐resistant epilepsy

Epileptic Disorders, EarlyView.
Matthew A. Hintermayer, Kenneth A. Myers
wiley   +1 more source